ScoreWhy is Gufic BioSciences Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 13.80% of over the last 5 years
2
The company has declared Negative results for the last 5 consecutive quarters
- INTEREST(9M) At Rs 27.17 cr has Grown at 46.94%
- PAT(Latest six months) At Rs 29.24 cr has Grown at -28.82%
- ROCE(HY) Lowest at 10.87%
3
With ROCE of 11.3, it has a Expensive valuation with a 3.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -15.68%, its profits have fallen by -38.4%
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.76% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -15.68% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Gufic BioScience for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Gufic BioScience
-14.58%
-0.45
32.42%
Sensex
-2.38%
-0.19
12.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.15%
EBIT Growth (5y)
13.80%
EBIT to Interest (avg)
4.80
Debt to EBITDA (avg)
2.11
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
1.42
Tax Ratio
26.56%
Dividend Payout Ratio
1.16%
Pledged Shares
0
Institutional Holding
4.18%
ROCE (avg)
21.42%
ROE (avg)
11.91%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
58
Industry P/E
31
Price to Book Value
4.62
EV to EBIT
32.12
EV to EBITDA
24.48
EV to Capital Employed
3.50
EV to Sales
3.56
PEG Ratio
NA
Dividend Yield
0.03%
ROCE (Latest)
11.34%
ROE (Latest)
9.02%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
NO KEY POSITIVE TRIGGERS
-12What is not working for the Company
INTEREST(9M)
At Rs 27.17 cr has Grown at 46.94%
PAT(Latest six months)
At Rs 29.24 cr has Grown at -28.82%
ROCE(HY)
Lowest at 10.87%
PBT LESS OI(Q)
At Rs 16.93 cr has Fallen at -5.1% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is not working for Gufic BioScience
Interest - Nine Monthly
At Rs 27.17 cr has Grown at 46.94%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit After Tax (PAT) - Quarterly
At Rs 12.42 cr has Fallen at -12.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 14.23 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 16.93 cr has Fallen at -5.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 17.84 CrMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
